RTW Investments is a New York, New York-based venture capital firm. Value Add VC tracks 3 companies RTW Investments has invested in and 2 venture rounds it took part in (0 as lead).
RTW Investments key facts (as of )
| Fact | Value | Source |
|---|---|---|
| Headquarters | New York, New York, USA | rtwfunds.com, September 15, 2026 |
| Type | Venture capital firm | Value Add VC classification |
| Assets under management | $14.1B | SEC Form ADV (IAPD), September 16, 2026 |
| Venture rounds tracked | 2 (led 0, joined 2) 2 in the last 12 months | Recent deals table on this page (each round cites its source) |
| Portfolio companies tracked | 3 | Portfolio list on this page |
Recent deals we track
3Track record: led 0 and participated in 2 of 2 tracked venture rounds · 2 in the last 12 months
| Date | Company | Event | Role | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|---|---|
| Oct 26, 2026 | Corxel Pharmaceuticals | ipo | Led | $377M | — | RTW InvestmentsLeadunverifiedNew Enterprise Associates (NEA)LeadunverifiedSR One Capital ManagementLeadunverifiedRA CapitalLeadunverifiedInvusLeadunverified | SEC EDGAR |
| Oct 23, 2026 | Zai Lab | funding round | Participated | $250M | — | Cormorant Asset ManagementunverifiedFrazier Life SciencesunverifiedRA CapitalunverifiedRTW InvestmentsunverifiedWellington ManagementunverifiedWorld Healthcare FundADAR1 Capital ManagementBalyasny Asset ManagementSirenia Capital Management+1 more | Pulse 2.0 |
| Sep 9, 2026 | Encoded Therapeutics | Series F | Participated | $275M | — | Google Ventures (GV)LeadARCH Venture PartnersIllumina VenturesInvusJanus Henderson InvestorsRTW InvestmentsSoftBank Vision FundVenrockBraidwellFarallon Capital ManagementMatrix Capital ManagementNolan Capital | Encoded Therapeutics (Business Wire via BioSpace) |
Is this your firm? Get featured or correct your listing →
We track RTW Investments but have little verified detail yet.
At a glance
RTW Investments appears in 2 funding rounds tracked by ValueAddVC since 2026. Its most recent tracked deal was Zai Lab's $250M round (Oct 23, 2026).
Strategy
Open Roles
6Recent changes
- Oct 23, 2026Oct 23, 2026Invested in Zai Lab ($250M) Pulse 2.0
- Sep 9, 2026Sep 9, 2026Invested in Encoded Therapeutics (Series F, $275M) Encoded Therapeutics (Business Wire via BioSpace)
Portfolio
3 totalCo-Investors
9Value Add Research
Latest Pulse
- Oct 26, 2026Corxel Pharma to Go Public Via $377M Amanat SPAC DealCorxel Pharmaceuticals, developer of obesity drug candidate CX11, will go public in the US through a SPAC merger with Amanat Acquisition Corp expected to deliver roughly $377 million in combined trust and PIPE proceeds.→
- Oct 23, 2026Zai Lab Raises $250M PIPE For DLL3 Cancer DrugAs of October 23, 2026, Nasdaq-listed Zai Lab has raised about $250 million in a PIPE financing, selling 11.34 million ADSs at $22.04 each to fund its DLL3-targeting antibody-drug conjugate, zocilurtatug pelitecan.→
RTW Investments FAQ
What stage does RTW Investments invest at?
In the rounds Value Add VC tracks, RTW Investments' deals were most often Series F (1).
What companies has RTW Investments backed?
Companies Value Add VC tracks as RTW Investments investments include Corxel Pharmaceuticals, Zai Lab and Encoded Therapeutics.
Where is RTW Investments based?
RTW Investments is headquartered in New York, New York, USA, according to rtwfunds.com.
Who does RTW Investments co-invest with most?
In the rounds Value Add tracks, RTW Investments most often invests alongside Invus (2 shared deals), RA Capital (2 shared deals), ARCH Venture Partners (1 shared deal), Frazier Life Sciences (1 shared deal), Google Ventures (GV) (1 shared deal).
Sources & methodologyshow
- SEC EDGARprimary source1 fact
- Encoded Therapeutics (Business Wire via BioSpace)research database1 fact
- Pulse 2.0research database1 fact
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.